Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

NCT01282801 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Teva Pharmaceuticals USA